ALLMedicine™ Infantile Hemangioma Center

Mar 17th, 2023 - Practice Essentials An arteriovenous malformation (AVM) is a defect in the vascular system in which a tangle of abnormal blood vessels directly connects the feeding arteries to a venous drainage network without the interposition of a capillary bed...

Mar 17th, 2023 - Practice Essentials An arteriovenous malformation (AVM) is a defect in the vascular system in which a tangle of abnormal blood vessels directly connects the feeding arteries to a venous drainage network without the interposition of a capillary bed...

Mar 17th, 2023 - Practice Essentials An arteriovenous malformation (AVM) is a defect in the vascular system in which a tangle of abnormal blood vessels directly connects the feeding arteries to a venous drainage network without the interposition of a capillary bed...

Feb 13th, 2023 - Infantile hemangiomas (IH) are common benign tumors of infancy. Most IH either involute spontaneously or respond to treatment with systemic Beta- blockers, but unfortunately not in all cases. In poor responses or in cases of contra indications for...

Feb 6th, 2023 - Infantile hemangioma (IH) is the most common tumor among infants, but the exact pathogenesis of IH is largely unknown. Our previous study revealed that glucose metabolism may play an important role in the pathogenesis of IH and that the inhibition...

Jan 18th, 2023 - Infantile hemangioma (IH) is the most common benign tumor of infancy with an estimated prevalence of 4%-5%. IHs may be presented in any part of body including the visceral organs, but are preferentially located on the face, head and neck area. IHs...

Jan 12th, 2023 - Primary: Describe the efficacy of 0.25% and 0.5% topical timolol maleate Gel-forming solution (GFS) as assessed through Infantile Hemangioma (IH) changes in volume. Secondary: Describe the safety of topical timolol maleate GFS for treatment of IH.

Jun 16th, 2022 - Currently, propranolol is the preferred treatment for problematic proliferating infantile hemangiomas (IHs). Although propranolol is clearly efficacious, rare side effects, such as hypoglycemia, may be life-threatening. The possibility of proprano...

Jun 14th, 2022 - Hereditary Hemorrhagic Telangiectasia (HHT) is a rare systemic autosomal dominantly inherited disorder of angiogenesis. Its major feature is the occurrence in 90% of patients of spontaneous and recurrent epistaxis responsible for iron deficiency a...

Apr 14th, 2022 - Material & Methods Study design: Randomised controlled trial Place of study: This is study was conducted in the department of paediatric surgery, children hospital, Pakistan institute of medical sciences, Islamabad Duration of study: 24 months Num...

Jan 10th, 2023 - Among patients with infantile hemangioma (IH), initiation of oral propranolol 3 mg/kg/day prior to 10 weeks of age was associated with a significantly better rate of treatment success, results from a post-hoc analysis of phase 2 and 3 clinical tri.

Dec 9th, 2022 - Drawing from clinical images, researchers trained an artificial intelligence (AI) algorithm to diagnose infantile hemangiomas with an overall accuracy of 91. 7%, a proof-of-concept study reported.

Aug 29th, 2022 - Women with cardiovascular conditions (CVCs) and ovarian cancer had better 2-year survival if they received a nonselective beta blocker (NSBB) at or around the time of cancer surgery, a review of medical records showed. Two-year postoperative survi...

May 11th, 2022 - BOSTON – As a former active-duty cavalry officer in the U.S. Army who served a 15-month tour in Iraq in 2003, Adam C. Byrd, MD, isn't easily rattled. On any given day, as the only dermatologist in his hometown of Louisville, Miss., which has a pop...

May 10th, 2022 - BOSTON – As a former active-duty cavalry officer in the U. S.